Clinical Trials · NCT04998136
Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 150
- Start date
- Aug 2022
- Locations
- 16 sites, South Korea, Thailand
- Primary endpoint
- Change in Body Weight (%) : In-trial Observation Period